Veterinary Medicines

Vanguard plus 7 liofilizat in vehikel za raztopino za injiciranje za pse

Authorised
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Canine parvovirus, strain NL-35-D, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain N-CDV, Live
Download as PDF

Product identification

Medicine name:
Vanguard plus 7 liofilizat in vehikel za raztopino za injiciranje za pse
Active substance:
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Canine parvovirus, strain NL-35-D, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine distemper virus, strain N-CDV, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
    40.00
    Protective Dose
    /
    1.00
    millilitre(s)
  • Leptospira interrogans, serovar Canicola, Inactivated
    40.00
    Protective Dose
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain NL-35-D, Live
    10000000.00
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parainfluenza virus, strain NL-CPI-5, Live
    1000000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, strain Manhattan, Live
    1584.00
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, strain N-CDV, Live
    1000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovenia
Available in:
  • Slovenia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
  • NP/V/0347/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 8/07/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 8/07/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Slovenian (PDF)
Published on: 8/07/2025
Download